Frank Hensel
Direktor/Vorstandsmitglied bei Mecuris GmbH
Profil
Frank Hensel is the founder of OncoMab GmbH, which was founded in 2002.
He held the title of Chief Executive Officer from 2002 to 2007.
Currently, Dr. Hensel is working as a Principal & Authorized Signatory at High-Tech Gründerfonds Management GmbH since 2015 and as a Board Member at Mecuris GmbH since 2018.
In his former positions, he worked as the Managing Director at Patrys GmbH, Vice President-Research & Development at Patrys Ltd., and as a Board Member at SciRhom GmbH from 2016 to 2020.
Dr. Hensel completed his graduate degree at the University of Osnabrück in 1994 and obtained his doctorate degree from Julius-Maximilians-Universität Würzburg in 1998.
Aktive Positionen von Frank Hensel
| Unternehmen | Position | Beginn |
|---|---|---|
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Private Equity Investor | 01.01.2015 |
Mecuris GmbH
 Mecuris GmbH Commercial Printing/FormsCommercial Services Mecuris GmbH operates a software platform for automatic generation of patient-customized orthoses and prosthetic designs. The company was founded by Manuel Opitz, Wolf-Peter Werner, Felix Gundlack, Jannis Breuninger and Simon Weidert and is headquartered in Munich, Germany. | Direktor/Vorstandsmitglied | 01.08.2018 |
Ehemalige bekannte Positionen von Frank Hensel
| Unternehmen | Position | Ende |
|---|---|---|
SciRhom GmbH
 SciRhom GmbH Miscellaneous Commercial ServicesCommercial Services SciRhom GmbH engages in the development of treatment for life-threatening diseases. The company was founded by Andreas Jenne, Jens Ruhein, Axel Ullrich, Carl Blobel and Matthias Schneider in 2016 and is headquartered in Planegg, Germany. | Direktor/Vorstandsmitglied | 31.03.2020 |
| Patrys GmbH | Vorstandsvorsitzender | 30.11.2015 |
OncoMab GmbH
 OncoMab GmbH Medical DistributorsDistribution Services OncoMab GmbH develops and markets human antibodies for cancer therapy. The company is headquartered in Wurzburg, Germany. | Gründer | 31.01.2007 |
| PATRYS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Frank Hensel
| University of Osnabrück | Graduate Degree |
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PATRYS LIMITED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
OncoMab GmbH
OncoMab GmbH Medical DistributorsDistribution Services OncoMab GmbH develops and markets human antibodies for cancer therapy. The company is headquartered in Wurzburg, Germany. | Distribution Services |
| Patrys GmbH | |
Mecuris GmbH
Mecuris GmbH Commercial Printing/FormsCommercial Services Mecuris GmbH operates a software platform for automatic generation of patient-customized orthoses and prosthetic designs. The company was founded by Manuel Opitz, Wolf-Peter Werner, Felix Gundlack, Jannis Breuninger and Simon Weidert and is headquartered in Munich, Germany. | Commercial Services |
SciRhom GmbH
SciRhom GmbH Miscellaneous Commercial ServicesCommercial Services SciRhom GmbH engages in the development of treatment for life-threatening diseases. The company was founded by Andreas Jenne, Jens Ruhein, Axel Ullrich, Carl Blobel and Matthias Schneider in 2016 and is headquartered in Planegg, Germany. | Commercial Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Finance |
